Abstract
Chlamydia pneumoniae is an important pathogen responsible for a variety of respiratory diseases in humans. Cell culture remains the most specific method for C. pneumoniae diagnosis, but it is labor-intensive and time-consuming. Thus, serology, particularly microimmunofluorescence (MIF) testing, is frequently utilized. However, the MIF test has a significant subjective component. We evaluated a new serological test: Chlamydia Immunoglobulin M (IgG, IgA, and IgM rELISAs Medac, based on a recombinant Chlamydia-specific lipopolysaccharide (LPS) fragment, for the diagnosis of C. pneumoniae infection. The results of this study demonstrated that the use of rELISAs Medac with single sera does not appear to be sensitive or specific for diagnosis of C. pneumoniae infection compared to culture. In children, sensitivities of the rELISAs compared to culture did not exceed 34.2%, and the specificities ranged from 68.4% (IgG) to 91.2% (IgA). In adults, the sensitivities of the rELISAs were slightly higher, up to 77.8% (IgA or IgG), but the specificities ranged from a very low 20.8% for IgA or IgG to 81.1% for IgM. When multiple sera were tested, the results of the rELISAs Medac correlated with culture results in five of eight (62.5%) patients. However, this offers only a retrospective diagnosis, which makes it difficult to manage these patients prospectively.
Full Text
The Full Text of this article is available as a PDF (69.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Block S., Hedrick J., Hammerschlag M. R., Cassell G. H., Craft J. C. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J. 1995 Jun;14(6):471–477. doi: 10.1097/00006454-199506000-00002. [DOI] [PubMed] [Google Scholar]
- Brade L., Brunnemann H., Ernst M., Fu Y., Holst O., Kosma P., Näher H., Persson K., Brade H. Occurrence of antibodies against chlamydial lipopolysaccharide in human sera as measured by ELISA using an artificial glycoconjugate antigen. FEMS Immunol Med Microbiol. 1994 Jan;8(1):27–41. doi: 10.1111/j.1574-695X.1994.tb00422.x. [DOI] [PubMed] [Google Scholar]
- Emre U., Roblin P. M., Gelling M., Dumornay W., Rao M., Hammerschlag M. R., Schachter J. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med. 1994 Jul;148(7):727–732. doi: 10.1001/archpedi.1994.02170070065013. [DOI] [PubMed] [Google Scholar]
- Grayston J. T., Campbell L. A., Kuo C. C., Mordhorst C. H., Saikku P., Thom D. H., Wang S. P. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis. 1990 Apr;161(4):618–625. doi: 10.1093/infdis/161.4.618. [DOI] [PubMed] [Google Scholar]
- Grayston J. T., Kuo C. C., Wang S. P., Altman J. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med. 1986 Jul 17;315(3):161–168. doi: 10.1056/NEJM198607173150305. [DOI] [PubMed] [Google Scholar]
- Griffiths P. C., Plater J. M., Horigan M. W., Rose M. P., Venables C., Dawson M. Serological diagnosis of ovine enzootic abortion by comparative inclusion immunofluorescence assay, recombinant lipopolysaccharide enzyme-linked immunosorbent assay, and complement fixation test. J Clin Microbiol. 1996 Jun;34(6):1512–1518. doi: 10.1128/jcm.34.6.1512-1518.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hyman C. L., Roblin P. M., Gaydos C. A., Quinn T. C., Schachter J., Hammerschlag M. R. Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis. 1995 May;20(5):1174–1178. doi: 10.1093/clinids/20.5.1174. [DOI] [PubMed] [Google Scholar]
- Kern D. G., Neill M. A., Schachter J. A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity. Chest. 1993 Jul;104(1):208–213. doi: 10.1378/chest.104.1.208. [DOI] [PubMed] [Google Scholar]
- Moss T. R., Darougar S., Woodland R. M., Nathan M., Dines R. J., Cathrine V. Antibodies to Chlamydia species in patients attending a genitourinary clinic and the impact of antibodies to C. pneumoniae and C. psittaci on the sensitivity and the specificity of C. trachomatis serology tests. Sex Transm Dis. 1993 Mar-Apr;20(2):61–65. doi: 10.1097/00007435-199303000-00001. [DOI] [PubMed] [Google Scholar]
- Numazaki K., Ikebe T., Chiba S. Detection of serum antibodies against Chlamydia pneumoniae by ELISA. FEMS Immunol Med Microbiol. 1996 Jun;14(2-3):179–183. doi: 10.1111/j.1574-695X.1996.tb00285.x. [DOI] [PubMed] [Google Scholar]
- Ozanne G., Lefebvre J. Specificity of the microimmunofluorescence assay for the serodiagnosis of Chlamydia pneumoniae infections. Can J Microbiol. 1992 Nov;38(11):1185–1189. doi: 10.1139/m92-194. [DOI] [PubMed] [Google Scholar]
- Peterson E. M., Cheng X., Qu Z., de La Maza L. M. Characterization of the murine antibody response to peptides representing the variable domains of the major outer membrane protein of Chlamydia pneumoniae. Infect Immun. 1996 Aug;64(8):3354–3359. doi: 10.1128/iai.64.8.3354-3359.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roblin P. M., Dumornay W., Hammerschlag M. R. Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol. 1992 Aug;30(8):1968–1971. doi: 10.1128/jcm.30.8.1968-1971.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Witkin S. S., Kligman I., Bongiovanni A. M. Relationship between an asymptomatic male genital tract exposure to Chlamydia trachomatis and an autoimmune response to spermatozoa. Hum Reprod. 1995 Nov;10(11):2952–2955. doi: 10.1093/oxfordjournals.humrep.a135827. [DOI] [PubMed] [Google Scholar]